Jeegar Pravinkumar Patel - 05 Nov 2025 Form 4 Insider Report for Evommune, Inc.

Role: Chief Scientific Officer
Signature: /s/ Gregory S. Moss, Attorney-in-Fact
Issuer symbol: EVMN on NYSE
Transactions as of: 05 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 07 Nov 2025, 16:15:14 UTC
Next filing: 12 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Patel Jeegar Pravinkumar	Chief Scientific Officer	C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO	/s/ Gregory S. Moss, Attorney-in-Fact	07 Nov 2025	0002092017

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVMN	Employee Stock Option (Right to Buy)	Award	$0	+179,619		$0.000000	179,619	05 Nov 2025	Common Stock	179,619	$16.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.